On 11/21/2024, David Arkowitz filed an initial statement of beneficial ownership with the SEC for iBio Inc. This filing, known as Form 3, indicates Arkowitz's position as a director and 10% owner of the company. Despite the filing, it is noted that no securities are beneficially owned by Arkowitz at this time.The document was submitted in compliance with Section 16(a) of the Securities Exchange Act of 1934. The filing was completed by Arkowitz individually, as indicated by the signature dated 11/25/2024. This form is a standard requirement for individuals who hold significant positions or ownership in a company, ensuring transparency in securities ownership.

On 11/21/2024, David Arkowitz filed an initial statement of beneficial ownership with the SEC for iBio Inc. This filing, known as Form 3, indicates Arkowitz's position as a director and 10% owner of the company. Despite the filing, it is noted that no securities are beneficially owned by Arkowitz at this time.The document was submitted in compliance with Section 16(a) of the Securities Exchange Act of 1934. The filing was completed by Arkowitz individually, as indicated by the signature dated 11/25/2024. This form is a standard requirement for individuals who hold significant positions or ownership in a company, ensuring transparency in securities ownership.